{"product_id":"riastap-fibrinogeo-fco-amp-1g","title":"Riastap (Fibrinogen) Vial Amp 1G","description":"\u003ch2\u003eCategory\u003c\/h2\u003e\n\u003cp\u003eHospital-use medications\u003c\/p\u003e\n\n\u003ch2\u003eLine\u003c\/h2\u003e\n\u003cp\u003eHemostatic medications\u003c\/p\u003e\n\n\u003ch2\u003eBrand\u003c\/h2\u003e\n\u003cp\u003eRiastap\u003c\/p\u003e\n\n\u003ch2\u003eMolecule\u003c\/h2\u003e\n\u003cp\u003eFibrinogen\u003c\/p\u003e\n\n\u003ch2\u003ePresentation\u003c\/h2\u003e\n\u003cp\u003e1G Vial\u003c\/p\u003e\n\n\u003ch2\u003eLaboratory\u003c\/h2\u003e\n\u003cp\u003eCsl Behring\u003c\/p\u003e\n\n\u003ch2\u003eIndications\u003c\/h2\u003e\n\u003cp\u003eRiastap is indicated for the treatment of patients with fibrinogen deficiency, including those with afibrinogenemia or hypofibrinogenemia. This medication is used in clinical situations requiring the restoration of adequate fibrinogen levels for proper blood clotting. It is recommended in cases of severe hemorrhages where fibrinogen levels are critically low and in surgical or invasive procedures in patients with coagulation disorders. Additionally, Riastap can be used to prevent or treat hemorrhages in patients with hematological disorders related to fibrinogen deficiency.\u003c\/p\u003e\n\n\u003ch2\u003eComposition\u003c\/h2\u003e\n\u003cp\u003eEach Riastap vial contains a lyophilized powder of human plasma-derived fibrinogen, which is reconstituted with a sterile solvent before administration. The concentration of fibrinogen, as well as the excipients used, are specified in the product leaflet.\u003c\/p\u003e\n\n\u003ch2\u003eContraindications\u003c\/h2\u003e\n\u003cp\u003eRiastap is contraindicated in patients with a history of hypersensitivity to any of its components or to human plasma-derived products. Its use should also be avoided in patients with coagulopathies unrelated to fibrinogen deficiency.\u003c\/p\u003e\n\n\u003ch2\u003ePrecautions\u003c\/h2\u003e\n\u003cp\u003eIt is important to monitor fibrinogen levels in patients during treatment. Caution should be exercised in those with a history of thrombosis or cardiovascular diseases, as fibrinogen administration may increase the risk of thrombotic events. Regular coagulation tests are recommended, and the dosage should be adjusted as needed.\u003c\/p\u003e\n\n\u003ch2\u003eStorage\u003c\/h2\u003e\n\u003cp\u003eRiastap should be stored in a cool, dry place, at a temperature not exceeding 25°C. Keep out of reach of children. Do not use after the expiry date indicated on the package.\u003c\/p\u003e\n\n\u003cp\u003eConsult your doctor\u003c\/p\u003e","brand":"Csl Behring","offers":[{"title":"Default Title","offer_id":46769846681825,"sku":"12157","price":14011.65,"currency_code":"MXN","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0722\/1500\/3361\/files\/WeCare-Pharma-Producto_f2804784-eeba-44b3-b36b-2007f8fa6b03.jpg?v=1755117715","url":"https:\/\/wecarepharma.mx\/en\/products\/riastap-fibrinogeo-fco-amp-1g","provider":"WeCare Pharma","version":"1.0","type":"link"}